These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36510182)

  • 1. Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis.
    Ueda T; Takaishi S; Yoshie T; Usuki N; Tatsuno K; Ohtsubo H; Araga T; Kaga Y; Takada T
    BMC Neurol; 2022 Dec; 22(1):477. PubMed ID: 36510182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
    Li A; Ye Z; Zhou W; Qin C
    Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcome of Balloon Angioplasty Without Stenting for Symptomatic Middle Cerebral Artery Stenosis.
    Ueda T; Takada T; Nogoshi S; Yoshie T; Takaishi S; Fukano T
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1870-1877. PubMed ID: 29530461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sole angioplasty with tiny balloon for high-risk complex symptomatic intracranial atherosclerotic stenosis].
    Qi P; Wang JJ; Wang LJ; Lu J; Hu S; Yang XM; Chen KP; Wang HF; Wang DM
    Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):458-463. PubMed ID: 29886671
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases.
    Zhang K; Li TX; Wang ZL; Gao BL; Gu JJ; Gao HL; Wang YF; Xia JC
    Sci Rep; 2021 May; 11(1):10479. PubMed ID: 34006896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon Angioplasty vs Medical Management for Intracranial Artery Stenosis: The BASIS Randomized Clinical Trial.
    Sun X; Deng Y; Zhang Y; Yang M; Sun D; Nguyen TN; Tong X; Peng G; Liu A; Xu Y; Wu Y; Geng X; Wang Y; Li T; Xing S; Wu W; Ji Y; Yang H; Wang S; Gao X; Yang W; Zhao X; Liu L; Ma N; Gao F; Mo D; Huo X; Song L; Li X; Zhang J; He H; Lv M; Mu S; Yu W; Liebeskind DS; Amin-Hanjani S; Wang Y; Wang Y; Miao Z;
    JAMA; 2024 Oct; 332(13):1059-1069. PubMed ID: 39235816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease.
    Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J
    Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis.
    Tang Y; Li T; Liu W; He Y; Zhu L; Wang ZL; He Y
    J Neurointerv Surg; 2023 Dec; 15(e3):e369-e374. PubMed ID: 36604174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcome of Angioplasty Using a Wingspan Stent, Post-Stent Balloon Dilation and Aggressive Restenosis Management for Intracranial Arterial Stenosis.
    Park SC; Cho SH; Kim MK; Kim JE; Jang WY; Lee MK; Jo KD; You SH
    Clin Neuroradiol; 2020 Mar; 30(1):159-169. PubMed ID: 31123775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients.
    Feng Z; Duan G; Zhang P; Chen L; Xu Y; Hong B; Zhao W; Liu J; Huang Q
    BMC Neurol; 2015 Oct; 15():187. PubMed ID: 26449986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation.
    Wang Y; Ma Y; Gao P; Chen Y; Yang B; Jiao L
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1487-1492. PubMed ID: 29976834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Stenting Plus Medical Therapy vs Medical Therapy Alone on Risk of Stroke and Death in Patients With Symptomatic Intracranial Stenosis: The CASSISS Randomized Clinical Trial.
    Gao P; Wang T; Wang D; Liebeskind DS; Shi H; Li T; Zhao Z; Cai Y; Wu W; He W; Yu J; Zheng B; Wang H; Wu Y; Dmytriw AA; Krings T; Derdeyn CP; Jiao L;
    JAMA; 2022 Aug; 328(6):534-542. PubMed ID: 35943472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural risk and long-term outcome of intracranial angioplasty based on a single-centre experience.
    Krajíčková D; Krajina A; Lojík M; Mulačová M; Vališ M
    Vasa; 2013 Jul; 42(4):264-74. PubMed ID: 23823858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complication of Stenting in Intracranial Arterial Stenosis.
    Zhang F; Liu L
    Arch Iran Med; 2016 May; 19(5):317-22. PubMed ID: 27179162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Asymptomatic Intracranial Atherosclerotic Stenosis Increase the 30-Day Risk of Stroke in Patients Undergoing Symptomatic Intracranial Atherosclerotic Stenosis Stenting.
    Zhao J; Li X; Chi LX; Ma BW; Du YH; Chen GS; Zhou HD; Li JC; Jiang XJ; Yang QW; Zhao XF; Yao XF
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):479-485. PubMed ID: 29056405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Tirofiban Before Stenting for Symptomatic Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.
    Zhang J; Huang X; Wang G; Wang X; Zhang T; Wang D; Qi L; Liang J; Li B; Chu J; Li K; Sun L; Song Y; Zhao W; Zheng M; Meng Y; Yin H; Wang W; Han J
    Neurology; 2024 Apr; 102(7):e209217. PubMed ID: 38489544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center.
    Miao ZR; Feng L; Li S; Zhu F; Ji X; Jiao L; Ling F
    Neurosurgery; 2009 Jan; 64(1):79-84; discussion 84-5. PubMed ID: 19050657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.